“Intentional Contamination: The Legal Risks and Responsibilities” was written for the Journal of Environmental Health. In the article, I address who is legally responsible for injuries sustained after a person becomes ill after consuming a product that was intentionally contaminated before it was purchased. Beyond the political implications of the use of food products as weapons, there is also the legal question of whether a company can be held liable for the criminal acts of an employee who decides, for whatever reason, to contaminate food products that then go on to make a number of people sick. To answer this question, we need first to discuss the rule of vicarious liability, or, as it is also known, respondeat superior–which is Latin for “let the superior make the answer.”
Denis Stearns, is of-counsel at Marler Clark, earned a BA in philosophy from Seattle University, and his law degree from the University of Wisconsin at Madison. He graduated from both schools with high honors, and won numerous awards for service and
A group representing the fish sector in Europe has welcomed regulation on tuna frozen in brine.
Europêche said the legislation recognizes the high sanitary and technological standards already applied by
The Dutch poultry sector has implemented measures to try and curb a rise in Salmonella infections.
Figures show an increased incidence of Salmonella Enteritidis in laying hens since May 2023
The annual report of a system that helps ensure safe trade involving Europe has revealed the scale and reasons for rejected shipments.
TRACES is the online platform of the Directorate-General
Rentokil is the world’s largest pest control company, operating in 90 countries worldwide. Its 2024 State of the Rodent Report is out. If you don’t like rats, this
OPINION
In an article that will soon be published in the Seattle Law Review, I take a look at food safety through the lens of the “pink slime” controversy and
“Ah, but a man’s reach should exceed his grasp, Or what’s a heaven for?”
— from Robert Browning’s “Andrea del Sarto”
Part 2: Does case law support FDA’
